Bedside chest scan to detect and monitor sudden lung blood clots
Tests a bedside, radiation-free chest scan for acute pulmonary embolism in adults.
Key facts
- Who runs it
- Beijing Tsinghua Chang Gung Hospital
- Where
- China4 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Pulsatile Electrical Impedance Tomography for Diagnosis and Monitoring of Acute Pulmonary Embolism
- Status
- Recruiting
- People taking part
- 275 people, planned
- Started
- 2 Jan 2026
- Expected to end
- 30 Dec 2028
- Type of study
- Observational, 4 groups
- Treatments tested
- Pulsatile Electrical Impedance Tomography
- Record updated
- 4 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with acute pulmonary embolism (a sudden blood clot in the lungs) confirmed by a CT scan of the lung arteries. It also takes people suspected of having one in whom it was not found, and healthy controls. It tests a bedside lung scan without radiation called pulsatile electrical impedance tomography (EIT).
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Acute pulmonary embolism confirmed by CT pulmonary angiography, newly diagnosed for the prospective part. Control groups: people suspected of having it in whom it was not confirmed, and healthy adults.
- Biomarker or test result
- Healthy controls must have normal D-dimer levels (a blood clot test) and a simplified Wells score ≤1. Prospective patients must have a body mass index less than 50 kg/m².
Main reasons for not taking part
- Earlier diagnosis of chronic pulmonary embolism or idiopathic pulmonary arterial hypertension
- Sudden worsening of COPD, acute heart failure, heart attack or other severe heart or lung disease
- Pregnancy or breastfeeding
- Chest deformity, or anything that blocks the EIT electrode belt, such as an implanted defibrillator, chest wounds or implanted pumps
- Unstable condition needing emergency rescue, or taking part in another clinical trial at the same time (prospective part)
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Adults aged 18 years or older. For retrospective PE cases: patients with acute pulmonary embolism confirmed by CT pulmonary angiography, with completed pulsatile electrical impedance tomography examination, adequate image data, and available clinical information; For retrospective healthy controls: adults without evidence of lower-extremity venous thrombosis, with normal D-dimer levels, simplified Wells score ≤1, and no pulmonary embolism-related symptoms or history; For prospective PE patients: patients newly diagnosed with pulmonary embolism by CT pulmonary angiography or CT pulmonary angiography plus CT venography, with body mass index less than 50 kg/m², who voluntarily participate and provide written informed consent; For prospective non-PE controls: patients with suspected acute pulmonary embolism who undergo CT pulmonary angiography or CT pulmonary angiography plus CT venography, but in whom pulmonary embolism is not confirmed, who voluntarily participate and provide written informed consent
Who cannot take part
- Previous diagnosis of chronic pulmonary embolism or idiopathic pulmonary arterial hypertension; Acute exacerbation of chronic obstructive pulmonary disease, acute heart failure, acute myocardial infarction, or other severe cardiopulmonary diseases that may interfere with study assessment; Pregnancy or lactation. Thoracic deformity. Contraindications to EIT examination, including automatic implantable cardioverter defibrillator, chest wounds limiting electrode belt placement, implanted pumps, or other conditions unsuitable for EIT electrode belt placement; Participation in another clinical trial during the same period, for prospective participants; Unstable vital signs requiring emergency rescue, leaving no time to complete EIT examination, for prospective participants; Any other condition considered unsuitable for participation by the investigators
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This multicenter observational diagnostic study aims to evaluate pulsatile electrical impedance tomography (EIT) for the diagnosis and monitoring of acute pulmonary embolism. The study includes a retrospective phase and a prospective phase. EIT-derived ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index will be compared with CT pulmonary angiography and relevant clinical indicators. The study is designed to assess whether EIT can provide a noninvasive, bedside, radiation-free method for pulmonary embolism diagnosis, risk stratification, and dynamic treatment monitoring.
The 4 groups in the trial
- Retrospective PE Cases
Patients aged 18 years or older with acute pulmonary embolism confirmed by CT pulmonary angiography, with completed pulsatile electrical impedance tomography examination and available clinical data in the retrospective phase.
Treatment: Pulsatile Electrical Impedance Tomography
- Retrospective Healthy Controls
Adults in the retrospective phase without evidence of lower-extremity venous thrombosis, with normal D-dimer levels, simplified Wells score ≤1, and no pulmonary embolism-related symptoms or history.
Treatment: Pulsatile Electrical Impedance Tomography
- Prospective PE Patients
Patients aged 18 years or older newly diagnosed with pulmonary embolism by CT pulmonary angiography or CT pulmonary angiography plus CT venography, who voluntarily participate and provide written informed consent.
Treatment: Pulsatile Electrical Impedance Tomography
- Prospective Non-PE Controls
Patients aged 18 years or older with suspected acute pulmonary embolism who undergo CT pulmonary angiography or CT pulmonary angiography plus CT venography, but in whom pulmonary embolism is not confirmed. These participants voluntarily participate and provide written informed consent in the prospective phase.
Treatment: Pulsatile Electrical Impedance Tomography
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Multicenter Retrospective and Prospective Diagnostic Observational Study of Pulsatile Electrical Impedance Tomography for Diagnosis, Risk Stratification, and Dynamic Monitoring of Acute Pulmonary Embolism
- Plain-language title
- Bedside chest scan to detect and monitor sudden lung blood clotsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 4 August 2026